Wave Life Sciences, Inc. (WVE) has 4 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 3 sales totalling $93K. Most recent filing: Aug. 13, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 13, 2026 filed Aug. 11, 2026 | Tan Aik Na Director | −$2,596 | 432 | −2% | Yes | |
|
|
||||||
| Aug. 13, 2026 filed Aug. 12, 2026 | Rawcliffe Adrian Director | −$67,183 | 12,700 | −100% | Yes | |
|
|
||||||
| Aug. 13, 2026 filed Aug. 11, 2026 | Wagner Heidi L Director | $280 | 21,000 | — | Yes | |
|
|
||||||
| Aug. 13, 2026 filed Aug. 11, 2026 | TAKANASHI KEN Director | −$23,223 | 3,864 | −16% | Yes | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free